Diarra M, Pourroy G, Muster D, Zingraff M, Boymond C
LEED Biomatériaux, Strasbourg, France.
Biomaterials. 1998 Aug;19(16):1523-7. doi: 10.1016/s0142-9612(98)00070-2.
In order to improve the administration of drugs for all pathology of the oral cavity, we have developed an intraoral controlled release delivering system, permitting to reach high enough local concentrations for desirable therapeutic effect with minimal side effects. We have formulated tablets of 200 mg intended to be fixed on a tooth. These tablets resist food and drink attacks. The tablets we elaborated have a granular matrix composed of hydroxyapatite, ethyl cellulose and Eudragit. Zinc sulfate is used as the first model of an active drug, it has a therapeutic effect on buccal mucous. Profiles of continuous in-vitro drug release in distilled water at 37 degrees C show that zinc sulfate release by the matrix structure for the different tablet formulations is regulated by the proportions of the different components.
为了改善针对口腔所有病变的药物给药方式,我们开发了一种口腔内控释给药系统,该系统能够以最小的副作用达到足够高的局部浓度以实现理想的治疗效果。我们制备了旨在固定在牙齿上的200毫克片剂。这些片剂能抵抗食物和饮料的侵蚀。我们精心制作的片剂具有由羟基磷灰石、乙基纤维素和丙烯酸树脂组成的颗粒基质。硫酸锌用作活性药物的首个模型,它对颊粘膜有治疗作用。在37摄氏度的蒸馏水中连续体外药物释放曲线表明,不同片剂配方中基质结构释放硫酸锌的过程受不同成分比例的调节。